Experiences of and recommendations on clinical trial design in Alzheimer’s disease from the participant’s point of view: a mixed-methods study in two clinical trial centers in the Netherlands

INTRODUCTION: In the context of the development of pharmaceutical interventions, expectations and experiences of participants are essential. Their insights may be particularly helpful to address the challenges of recruiting and retaining participants for Alzheimer’s disease (AD) clinical trials. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Ottenhoff, Lois, Vijverberg, Everard G. B., Visser, Leonie N. C., Verijp, Merike, Prins, Niels D., Van der Flier, Wiesje M., Sikkes, Sietske A. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071606/
https://www.ncbi.nlm.nih.gov/pubmed/37016435
http://dx.doi.org/10.1186/s13195-023-01190-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071606/
https://www.ncbi.nlm.nih.gov/pubmed/37016435
http://dx.doi.org/10.1186/s13195-023-01190-0

Ejemplares similares